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1. Introduction 
Radiation has been considered an enigma to the general public and the use of radiation for 
therapeutic and other uses has always been associated with some skepticism. Presently, 
ionizing radiation is being used in a large number of therapeutic, industrial and other 
applications apart from for the generation of nuclear power, developing new varieties of 
high-yielding crops and enhancing storage period of food materials. Radiation treatment is 
an important therapeutic option for a number of malignancies, but its use is frequently 
limited due to adverse effects on normal tissues because it generates reactive oxygen species 
(ROS) such as hydroxyl radical (·OH), superoxide radicals (O2-.), singlet oxygen and peroxyl 
radicals (ROO.) in irradiated tissue that induce several pathophysiological changes in the 
body. The goal of most cancer treatments is to maximize the antineoplastic effect while 
minimizing harmful side effects for the patient.  
Due to the increased use of ionizing radiation in various aspects of human life, there is a 
need to develop an effective and non-toxic radioprotector. Radioprotectors are compounds 
that are designed to reduce the damage in normal tissues caused by radiation. These 
compounds are often antioxidants and must be present before or at the time of radiation for 
their effectiveness. Other agents, termed mitigators, may be used to minimize toxicity even 
after radiation has been delivered. Many natural and synthetic chemicals have been 
investigated in the recent past for their efficacy to protect against radiation-induced damage 
in biological systems (Maurya et al. 2006). Though a large number of compounds have been 
shown to be promising as radioprotectors in laboratory studies, few could pass the 
transition from bench to bedside. In fact, no radioprotective agent is now available, either 
alone or in combination to meet all the requisites of an ideal radioprotector. Amifostine is 
the only one that is currently in use having good radioprotection, even though there are 
reports about contraindications in some cases. Different radioprotectors offer protection to 
cellular molecules by different mechanisms (Maurya et al. 2006). Some of these compounds 
protect the target molecules because of their antioxidant mechanism by neutralizing the free 
radical, some enhances the cellular DNA repair (Maurya et al. 2005a; Maurya et al. 2005b), 
some modified the signaling pathways, some modulate the immune system and some 
contribute to a combination of all above mentioned mechanisms.  
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Radiation-induced DNA double-strand breaks are believed to be important lesions and the 
key trigger leading to a series of cellular consequences related to cell killing, gene mutation, 
induction of chromosome aberrations and carcinogenesis. There are two major cellular 
intrinsic factors deciding the extent of DNA damage in the irradiated cells, i.e. the activity of 
antioxidant systems and the capacity of DNA repair. There are two distinct but 
complementary mechanisms for DNA DSB repair namely; non-homologous end joining 
(NHEJ) and homologous recombination (HR) involving various repair proteins to execute 
the repair process. When discussing about a single or a group of radioprotectors, one has to 
keep in mind that radioprotective effect is an ability of radioprotectors to inhibit indirect 
effect and to repair direct and indirect damages occurred in the cells after radiation 
exposure. Discussions of all the molecular steps are out of the chapter’s scope. In this 
chapter we are going to discuss a series of consequences happening after irradiation, types 
of damages induced, possible role of radioprotectors in preventing DNA damage and 
modulating DNA repair. At the end the future prospects for radioprotectors in mitigation of 
radiation damage will be discussed.  
2. Consequences of radiation exposure on cells/ tissues and possible role of 
radioprotectors  
Exposure of living cells/ tissues to ionizing radiation causes damages by transfer of energy 
to atoms and molecules in the cellular structure. Ionizing radiation causes either excitation 
or ionization or both to atoms and molecules. These excitations and ionizations can lead to 
following events inside the cells/ tissues;  
i. Generation of free radicals 
ii. Breakage of chemical bonds 
iii. Formation of new chemical bonds and cross-linkage between macromolecules.  
iv. Damage to biomolecules (e.g. DNA, RNA, lipids, proteins) which regulate vital cell 
processes 
To understand the mechanism of action of radioprotectors, an in-depth knowledge of 
fundamental radiobiological events happening during and shortly after irradiation in tissues 
and cells is essential. Scheme 1 depicts the series of events happening in cells/ tissues 
following radiation exposure. Radiation causes damage to cells/ tissues by both direct and 
indirect actions. During direct action, the radiation is directly causing irreparable damage to 
critical targets within the cell, such as DNA, RNA, proteins and lipids. In indirect action, 
radiation interacts with other molecules of the cell that are not critical targets but are close 
enough to pass on this damage, typically in the form of free radicals. Indirect action of 
ionizing radiation is due to free radicals, generated during radiolysis. Because body is 
composed of >80% water, indirect effect is important due to the radiolytic products, mainly 
the hydroxyl free radical, which is an effective oxidant capable of breaking chemical bonds, 
initiating lipid peroxidation, in the nano- to microsecond timeframe. After radiation 
exposures following changes are observed in DNA at the molecular level namely single- or 
double-strand breaks (DSB), base damage, and DNA-DNA or DNA-protein cross-links 
(Maurya et al. 2006). If different damages following radiation exposure not repaired, they 
affect the cell structure and function. After DNA damage has occurred, a number of 
processes occur in the damaged cell, tissue, or organism, including activation of DNA repair, 
activation of signal transduction, expression of radiation response genes and stimulation of 
proliferation etc. These pathways can be important for cell or tissue recovery after radiation 
exposure but may also play a role in the development of toxicity.  
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Fig. 1. Chain of the cellular event occurring in the cell/ tissue after ionizing radiation 
exposure.  
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3. Types of damages induced after radiation exposure 
Ionizing radiation can produce different types of damage to DNA, RNA, proteins and other 
biomolecules. DNA is the major target of radiation induced damage where as membrane is 
an alternative target. Because the portion of water in living matter is quite high, radiolytic 
product of the water, mainly hydroxyl radical is responsible for most damages to 
biomolecules. Hydroxyl radical causes damages to biomolecules by abstracting an H-atom 
from the biomolecules (from the sugar moiety of the DNA or from the peptide chain of a 
protein) or by addition of the double bonds of aromatic moieties (DNA bases or aromatic 
moieties of protein side chain) (Spothem-Maurizot et al. 2008).  
Ionizing radiation causes the formation of strand breaks in cellular DNA, as well as other 
types of lesions in the chromatin of cells(Roots et al. 1985). The amount of DNA damage 
induced is determined by type of radiation as well as the presence of other molecular 
components in close proximity to DNA, in particular the presence of proteins because it is 
well known that most molecular interactions between proteins and DNA occur via amino 
acids. It is estimated each gray (Gy) of radiation leads to about 100,000 ionizations within a 
cell, damage to over 1,000 bases, about 1,000 SSBs and about 20 – 40 DSBs. Despite this, 1 Gy 
kills only 30% of mammalian cells due to the effectiveness of DNA repair - particularly for 
non-DSB lesions (Spothem-Maurizot et al. 2008).  
Lipid peroxidation has been found as the main damage to membrane lipids and 
lipoproteins. Ionizing radiation induced lipid oxidative modifications of poly unsaturated 
fatty acids (PUFAs) appears as a dynamic process initiated by hydroxyl free radicals 
generated by water radiolysis, amplified by a propagating-chain mechanism involving alkyl 
and peroxyl free radicals, and leading not only to hydroperoxides but also to a lot of other 
lipidic oxidized end-products, lipid hydroperoxides and conjugated dienes which are early 
products of lipid peroxidation (Spothem-Maurizot et al. 2008). 
During ionizing radiation induced damage to protein, the type of reactions and 
consequences are quite similar to those of DNA; abstraction of H atoms and binding to 
aromatic rings, leading to backbone breakage and modification of side chains. All these 
event leads to peptide chain fragmentation and modification of amino acid side chain 
(e.g.Trp/formylkynurenine, Tyr/bityrosine,Cys/disulfide) (Spotheim-Maurizot and 
Davidkova 2011).  
4. Classification of radioprotective agents  
Radioprotective agent can be defined as “any agent that protects against radiation-induced 
damage, whether administered before, during, or after irradiation”. They have been 
classified into three categories; i. Prophylactic agents, ii. Mitigators, and iii. Therapeutic agents 
(Stone et al. 2004). Prophylactic agents are administered before radiation exposure to 
prevent damage. ‘Mitigators’ designates agents that are administered during or after 
radiation exposure with the aim of preventing or reducing the action of radiation on tissues 
before the appearance of symptoms. These agents include decorporation and chelating 
agents that mitigate injury from internal radionuclide exposure. They also include blocking 
agents that mitigate the uptake of radionuclides by specific organs; for example, potassium 
iodide (KI) protects the thyroid from radioiodine. Therapeutic agents are administered after 
radiation exposure to treat or facilitate recovery from various aspects of the acute radiation 
syndrome (ARS) and delayed effects of radiation exposure(Weiss and Landauer 2009). The 
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putative mechanism of radioprotection by plant and herbal radioprotectors may be 
mediated through several mechanisms, since they are complex mixtures of many chemicals 
(Jagetia 2007) but this may or may not be true with the pure compounds. Table 1 is a list of 
some radioprotective agents with their possible radioprotective properties.  
 
Radioprotectors/ 
mitigators and 
therapeutics 
Protective property Ref. 
Amifostine  
(WR-2721) 
This is the most effective thiol protector still today. 
Administration of WR-2721 intramuscularly (IM) at 300 mg/kg 
in mice 15 min before radiation, a DRF of 2.7 was obtained with 
protection observed when injected up to 2 h before irradiation. 
(Kuna 1983) 
Manganese (III) 
tetrakis (N-methyl-
2-pyridyl)porphyrin
Administration for 14 days at a daily dosage of 5 mg/kg 
provided protection against oxidative damage and lethality in 
mice exposed to total body irradiation (TBI). 
(Lee and Park 
2004) 
Melatonin Oral administration of 20 mg/ mouse (approximately 800 
mg/kg) of melatonin 30 min before irradiation significantly 
protected intestinal crypt cells. It inhibits chromosomal 
aberrations and micronuclei formation in lymphocytes. When 
melatonin treated mice were irradiated at an LD50/30 dose (8.15 
Gy), survival increased to 85% in the group injected with 250 
mg/kg melatonin administered 1 h before irradiation. In a 
model of acute lung injury in rats, administration of 100 mg/kg 
melatonin before radiation exposure resulted in decreased 
inflammation but promoted fibrosis. 
(Monobe et al. 
2005); 
(Vijayalaxmi et 
al. 1999); 
(Vijayalaxmi et 
al. 1996); (Serin 
et al. 2007) 
ACE inhibitors  They prevent the development of radiation-induced late effects 
including damage to the kidney and lung. When the ACE 
inhibitor perindopril was administered to mice for two days 
before and two days after a lethal dose of gamma-radiation, a 
significant increase in survival was observed ACE inhibition 
accelerated hematopoietic recovery and increased the number of 
hematopoietic stem cells. Protection was mediated by inhibition 
of the angiotensin II pathway through the AT1 receptor because 
similar effects were obtained with an AT1 receptor antagonist. 
(Charrier et al. 
2004; Moulder 
and Cohen 2007) 
CDK4/6 inhibitors Entry into the cell cycle is mediated by cyclin-dependent kinase 
4/6 (CDK4/6) activation, followed by CDK2 activation. Johnson 
et al. have explored the role of cyclin-dependent kinase 
inhibitors (CDKIs) in the control of the transition from G1 to S 
phase in ionizing radiation–induced cell toxicity. They 
confirmed that inhibitors specific for CDK4/6, specifically 
PD0332991 and 2BrIC, caused reversible G1 arrest 
(pharmacological quiescence) exclusively in Rb-positive and not 
Rb-deficient human cells. They also reported that in mice, oral 
administration of PD0332991 resulted in reversible inhibition of 
proliferation of different populations of bone marrow cells. 
Same group also found that PD0332991 markedly enhanced the 
survival of mice, when applied as late as 20 h after total body 
irradiation, thus, it acted as a radiomitigator. 
(Johnson et al. 
2010) 
Growth factors 
such as Palifermin, 
They are FDA approved growth factors. Palifermin specifically 
decrease the incidence and duration of severe oral mucositis in 
(Spielberger et 
al. 2004) 
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Radioprotectors/ 
mitigators and 
therapeutics 
Protective property Ref. 
Filgrastim patients with hematologic cancers undergoing high-dose 
chemotherapy, with or without irradiation, followed by bone 
marrow transplantation. 
Chelators such as 
diethylenetriamene 
pentaacetate 
(DTPA) 
DTPA is a FDA-approved agents and includes the calcium and 
zinc salts, used for the chelation of the transuranic radionuclides 
plutonium, americium, and curium; Prussian blue for 
decorporation of 137Cs; and KI to block uptake of radioactive 
iodine by the thyroid. 
 
Selenium 
compounds such as 
Selenomethionine 
(SeM) and Sodium 
selenite 
SeM is a naturally occurring derivative of selenium, found in 
soya, grains, legumes, and selenium-enriched yeast (Whanger 
2002). When administered i.p., SeM (4 mg/kg Se) significantly 
increased the survival of mice irradiated at 10-Gy 60Co at a low 
dose rate (0.2 Gy/min). 
(Damron et al. 
2004; Diamond 
et al. 1996) 
Orientin and 
vicenin from 
Ocimum sanctum 
DRF for 30-days survival in mice treated 30 min before 
irradiation with low doses (50 mg/kg) i.p. were 1.30 for orientin 
and 1.37 for vicenin. The same low doses of orientin or vicenin 
provided efficient protection against bone marrow damage, as 
measured by chromosomal aberrations and stem cell survival 
using the exogenous colony-forming unit spleen (CFU-S) assay. 
(Nayak and 
Devi 2005; Uma 
Devi et al. 2000) 
Genistein A DRF of 1.16 was obtained at a genistein dose (200 mg/kg SC) that 
did not result in any adverse pathology or behavioural toxicity. 
(Landauer et al. 
2003) 
Table 1. A list of well known radioprotectors, mitigators and therapeutics. 
5. Role of radioprotectors in inhibition of DNA damages and enhancement of 
DNA repair after radiation exposure  
In order to restore the cellular function DNA repair is our important parameter that can be 
modified by radioprotective compounds to improve the radioprotection. Most of the cellular 
alterations induced by ionizing radiation is indirect and is mediated by the generation of 
free radicals and related reactive species, mainly derived from oxygen. Hence natural 
compounds with antioxidant activity have potential as good radioprotectors. Though a large 
variety of compounds have shown promise as radioprotector in laboratory studies, most of 
them failed even before reaching the preclinical stage due to toxicity and side effects.  
Protection of cellular molecules including DNA from radiation can be achieved by various 
mechanisms. Protection to cellular DNA can be achieved by reducing the quantity of 
damage (by radical scavenging and chemical repair) followed by enhancement of 
biochemical repair of DNA to improved protection and recovery. Thus DNA repair is one of 
the important parameters that can be modified to attain improved protection. Many natural 
and related compounds are shown to be effective radioprotectors. They protect cellular 
molecules including DNA by various mechanisms. These include their antioxidant capacity 
and induction of repair mechanisms. Our studies have identified many compounds with 
radioprotective ability using in vitro, ex vivo and in vivo model systems. The systems used 
are rat liver and brain sub-cellular organelles, plasmid DNA, human lymphocytes, 
mammalian cells in culture and mouse. Different parameters also have been used to 
estimate damage and protection. Our studies have identified caffeine, chlorophyllin, 
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flavonoid troxerutin, ferulic acid present in cereals, the food flavoring agent vanillin and 
tocopherol-mono-glucoside among others as effective radioprotectors. Details of some of 
these molecules are given below.  
5.1 Alpha tocopherol monoglucoside (TMG) 
TMG, a water-soluble derivative of Vitamin E, has been reported to be a good 
radioprotector with low toxicity (Kapoor et al. 2002; Nair et al. 2004; Rajagopalan et al. 2002). 
It has been reported that an oral administration of 2 g/kg body weight of TMG, five minutes 
prior to radiation exposure, resulted in early recovery of the radiation-induced weight loss 
(Nair et al. 2003). Embryonic death, resulting from exposure to 2 Gy radiation in pregnant 
mice, was reduced by 75% with a single intra peritoneal injection of TMG (0.6 g/kg body 
weight) prior to the radiation exposure. However, the administration of TMG after the 
radiation exposure did not have any effect on the embryonic mortality (Nair et al. 2003). A 
single intra peritoneal injection of TMG (0.6 g/kg) to mice, after whole body irradiation, 
elevated the LD50 (30) from 6 to 6.72 Gy (Nair et al. 2003). Radiation induced formation of 
micronucleated polychromatic and normochromatic erythrocytes in mouse bone marrow 
cells was inhibited by a single injection of TMG (0.6 g/kg body weight) i.p. after the 
radiation exposure with a dose reduction factor of 0.5 (Satyamitra et al. 2001). Our in vitro 
studies, either with humans or mice, peripheral blood leucocytes showed that the presence 
of TMG (0.5 mM) in post-irradiation incubation medium did not enhance the repair of DNA 
strand breaks(Salvi et al. 2007). TMG is also effective in preventing radiation-induced bone 
marrow death in mice and enhance hematopoietic recovery (Ueno et al. 2009), 
(Cherdyntseva et al. 2005). 
5.2 Baicalein  
Baicalein (scheme 2A), has been reported to possess lipid peroxidation inhibitory activity. 
Our results indicate that baicalein is a potent radioprotector at micromolar (5-50) levels. The 
protective effect, at 5 μM, was 80% against formation of thiobarbituric acid reactive 
substances (TBARS) and 50% against lipid hydroperoxide. The protective ability against 
protein carbonyl formation was 50% and protein hydroperoxide formation 85% at the same 
concentration. Similar protective effects were also observed against damage to glutathione 
peroxidase and superoxide dismutase. A concentration dependent effect also was seen with 
most of the parameters examined. Single-strand break formation induced by radiation also 
was accentuated with baicalein. It also inhibited the DNA binding caused by radiation. 
(Tilak and Devasagayam 2003). Recently it was found that baicalein has a radioprotective 
effect against NF-κB-mediated inflammatory response through MAPKs and the Akt 
pathway (Lee et al. 2011).  
5.3 Caffeine  
Caffeine is a bitter, white crystalline xanthine alkaloid that is a psychoactive stimulant 
present in coffee and cola-based soft drinks. In humans, caffeine acts as a central nervous 
system (CNS) stimulant, temporarily warding off drowsiness and restoring alertness. We 
have shown that caffeine protected against DNA strand breaks in plasmid pBR322, a system 
devoid of repair and replication machinery (Kumar et al. 2001). This protective effect was 
related to the demonstrated antioxidant properties of caffeine in vitro, including scavenging 
of primary and secondary ROS (Devasagayam et al. 1996). Pretreatment with caffeine at 
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doses of 5 or 15 mg/kg, administered either i.p. or in drinking water, reduced radiation-
induced frequency of chromosomal aberrations. Farooqi and Kesavan, had shown that 
administration immediately after radiation exposure also significantly reduced chromosome 
aberrations (Farooqi and Kesavan 1992). In our other study, George et al showed that when 
caffeine (80 mg/kg) was administered i.p. 1 h before irradiation it increases the survival of 
the mice (George et al. 1999). Radioprotection in mice at the same dose of caffeine may be 
related to modulation of radiation-induced apoptotic genes, for example, the depression of 
bax mRNA (Kim et al. 2003). This same high dose of caffeine protected against local 
radiation (35 Gy) skin reactions of mice. However, caffeine injection into a mouse 
fibrosarcoma did not affect the tumor response to irradiation (Hebbar et al. 2002). 
5.4 Chlorophyllin  
Chlorophyllin (CHL) (scheme 2B), is a water-soluble mixture of sodium-copper salts of 
green plant pigment, chlorophyll. CHL is widely marketed for a variety of dietary and 
medicinal uses. Recently, it has also been shown to occur naturally in a constituent of 
traditional Chinese medicine (Chiu et al. 2003). It has chemopreventive, antimutagenic and 
anticarcinogenic properties (Egner et al. 2001; Guo et al. 1995). Our lab has explored it 
radioprotective property in various model systems. It exhibited protection against radiation 
and chemical induced cytogenetic damage (Kumar et al. 1999)). CHL inhibited lipid 
peroxidation induced by 2,2'-azobis(2-propionimidinedihydrochloride) (AAPH) in 
lymphocytes in vitro. It also partially prevented radiation-induced suppression of mitogenic 
stimulation of lymphocytes in vitro (Kumar et al. 2004).  
5.5 Ferulic acid  
Ferulic acid (FA) (Scheme 2C) is a monophenolic phenylpropanoid occurring in plant 
materials such as rice, green tea and coffee beans. It is well known antioxidant and has 
ability to scavenge the free radicals. As for toxicity of this compound, no in vivo data is 
available, but in vitro cytotoxicity in rat hepatocytes showed an LD50 of 25 mM (Maurya et 
al. 2005b). We have explored the effect of ferulic acid on gamma-radiation-induced 
relaxation of plasmid pBR322 DNA and induction of DNA strand breaks in peripheral blood 
leukocytes and bone marrow cells of mice exposed to whole body gamma-radiation. 
Presence of 0.5 mM ferulic acid significantly inhibited the disappearance of supercoiled (ccc) 
plasmid pBR322 with a dose modifying factor (DMF) of 2.0. Intraperitoneal administration 
of different amounts (50, 75 and 100 mg/kg body weight) of FA 1 h prior to 4Gy gamma-
radiation exposure showed dose-dependent decrease in the yield of DNA strands breaks in 
murine peripheral blood leukocytes and bone marrow cells as evidenced from comet assay. 
The dose-dependent protection was more pronounced in bone marrow cells than in the 
blood leukocytes. It was observed that there was a time-dependent disappearance of 
radiation induced strand breaks in blood leukocytes (as evidenced from comet parameters) 
following whole body radiation exposure commensurate with DNA repair (Maurya et al. 
2005b). Administration of 50 mg/kg body weight of FA after whole body irradiation of mice 
resulted disappearance of DNA strand breaks at a faster rate compared to irradiated 
controls, suggesting enhanced DNA repair in FA treated animals. When normal and tumor 
cells were treated with FA and the DNA damage measured after radiation exposure it was 
found that FA is having preferential protection to normal cells compared to tumor cells both 
under ex vivo and in vivo conditions (Maurya and Nair 2006). Recently, Ma et al have 
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suggested that the radioprotective efficacy by FA may be a result of early recovery of 
hematopoietic cells due to enhanced production of G-CSF and erythropoietin (Ma et al. 
2011a). They have also reported that FA had a radioprotective effect through the ERK 
pathway to inhibit apoptosis and oxidation (Ma et al. 2011b).  
5.6 Troxerutin  
Troxerutin (Scheme 2D), a derivative of the natural flavonoid rutin extracted from Sophora 
japonica (Japanese pogoda tree) has been commonly used in the treatment of Chronic 
Venous Insufficiency (CVI) disease (Lefebvre and Lacombe 1991). In clinical trials, 
troxerutin has been given in doses up to 7 g per day orally for up to 6 months with no 
contraindications (Glacet-Bernard et al. 1994). It has been reported that during radiotherapy 
of head and neck cancer, administration of a mixture of troxerutin and coumarin offered 
protection to salivary glands and mucosa. We have shown that troxerutin inhibited lipid 
peroxidation in membrane of sub-cellular organelles as well as normal tissues of tumor-
bearing mice exposed to gamma-radiation. Further, it was found that administration of 
troxerutin resulted in differential protection of DNA in blood leucocytes and bone marrow 
cells and not in cells of tumor in whole body irradiated tumor-bearing mice. Troxerutin 
protected the human peripheral blood leucocytes from radiation-induced DNA strand 
breaks in a concentration dependent manner under ex vivo condition of irradiation (2Gy)  
 
 
Fig. 2. A. Baicalein, B. Chlorophyllin, C. Ferulic acid, D. Troxerutin, E. Vanillin. 
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(Maurya et al. 2004). Intraperitoneal administration of troxerutin (175 mg/kg body weight) 
to mice before and after whole body radiation exposure inhibited micronuclei formation in 
blood reticulocytes significantly. The administration of different doses (75, 125 and 175 
mg/kg body weight) of troxerutin 1 h prior to 4 Gy gamma-radiation exposure showed 
dose-dependent decrease in the yield of DNA strand breaks in murine blood leucocytes and 
bone marrow cells. The dose-dependent protection was more pronounced in bone marrow 
cells than in blood leucocytes. Administration of 175 mg/kg body weight of the drug (i.p.) 1 
h prior or immediately after whole body irradiation of mice showed that the decrease in 
strand breaks depended on the post-irradiation interval at which the analysis was done. 
Measurement of DNA repair potential of the troxerutin shows that it enhances the DNA 
repair (Maurya et al. 2005a). So the observed time-dependent decrease in the DNA strand 
breaks could be attributed to enhanced DNA repair in troxerutin administered animals.  
5.7 Vanillin  
Vanillin (4-hydroxy-3-methoxybenzaldehyde), scheme 2E, is a compound used as a 
flavoring agent and as a dietary component. It is the major component of natural vanilla, 
which is one of the most widely used and important flavoring materials throughout the 
world. The source of vanilla is the bean, or pod, of the tropical Vanilla orchid (principally 
Vanilla planifolia Andrews, syn. V. fragrans (Salisb. Ames)). Vanillin is an antioxidant capable 
of protecting membrane against lipid peroxidation and DNA against strand breaks induced 
by reactive oxygen species like singlet oxygen. Vanillin and its analogs were strongly anti-
mutagenic or anti-genotoxic in most studies. Vanillin also suppresses the chromosomal 
aberrations induced by X-rays in V79 cells in vitro (Keshava et al. 1998) and in mice in vivo 
(Sasaki et al. 1990). Imanishi et al. have shown anti-mutagenic effect of vanillin against UV 
and X-rays in Chinese hamster V79 cells (Imanishi et al. 1990). We have explored the effect 
of vanillin on radiation-induced DNA damage in plasmid pBR322 (in vitro), human 
peripheral blood leucocytes and mouse splenic lymphocytes (ex vivo) and in mouse (in vivo), 
besides the possible mechanisms involved in terms of scavenging radiation related free 
radicals by pulse radiolysis. Our finding shows that presence of 0.5mM vanillin has a dose-
modifying factor (DMF) of 6.75 for 50% inactivation of ccc form. Exposure of human 
peripheral blood leucocytes (ex vivo) to radiation causes strand breaks in the cellular DNA, 
as assessed by comet assay. When leucocytes were exposed to 2 Gy of -radiation there was 
an increase in parameters of comet assay such as %DNA in tail, tail length, ‘tail moment’ 
and ‘Olive tail moment’. The presence of 0.5 mM vanillin during irradiation significantly 
reduced these parameters. Damage to DNA in mouse peripheral blood leucocytes after 
whole-body exposure of mice (in vivo) to radiation was studied at 1 and 2 h post-irradiation. 
There was recovery of DNA damage in terms of the above-mentioned parameters at 2h 
post-irradiation. This was more than that observed at 1 h (Maurya et al. 2007). The recovery 
was more in vanillin treated mice. Hence our studies showed that vanillin offers protection 
to DNA against radiation-induced damage possibly imparting a role other than modulation 
of DNA repair (Maurya et al. 2007).  
6. Future prospects for radioprotectors in mitigation of radiation damage 
Research in the development of radioprotectors worldwide has focused on screening a 
variety of chemical and biological compounds (Maurya et al. 2006; Nair et al. 2001; Weiss 
and Landauer 2009). Various natural or synthetic compounds having either antioxidant or 
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cytoprotective or immunomodulatory property or their combination have been evaluated 
extensively for their radioprotective potentials in both in vitro and in vivo models (Maurya 
et al. 2006; Weiss and Landauer 2009). So far no synthetic radioprotective molecule is 
available that is perfectly safe and effective. Herbal origin radioprotectors have a hope to 
overcome the toxicity issues seen with the synthetic compounds. There are many reports on 
the pre-irradiation radioprotectors, using synthetic or natural compounds. There are hardly 
a few post-irradiation radioprotectors. Such radioprotectors based on induction of DNA 
repair and related mechanisms will have great potential in reducing accidental exposure 
such as those that occur due to natural calamities like earthquakes and tsunami as in the 
case of Fukushima daiichi nuclear reactors. To overcome this kind of situation, there is a 
need to locate more effective post-irradiation effective radioprotector that can enhance the 
DNA repair. Since the DNA is the critical target for ionizing radiation, future, studies 
should focus on compounds that have potential to enhance the process of DNA repair 
which is essential after radiation exposure. These also can be used in other cases of exposure 
such as that of radiotherapy for cancer.  
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